Clinical Trial Update: A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating plasma concentrations, metabolism, and excretion of 14C-labeled paliperidone after a single oral dose in participants w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED